Tumor ablation is a minimally invasive treatment to eradicate cancer cells and tumors. Its numerous advantages include facilitating a faster and easier recovery process for patients, particularly those reluctant to undergo surgery. Furthermore, tumor ablation ensures precise targeting and destruction of tumor cells while minimizing damage to healthy, unaffected cells. This approach relieves patients and offers an effective means of treatment that minimizes risks and promotes a quicker return to health.
According to Data Bridge Market Research, the Tumor Ablation Market accounted for USD 96.65 million in 2022 and is expected to reach USD 269.95 million by 2030. The market is expected to grow with a CAGR of 13.70% in the forecast period of 2023 to 2030.
“Increasing demand for surgical ablation”
The rising prevalence of liver and breast cancer and limited access to advanced tumor ablation techniques for these organs is anticipated to drive market growth. These procedures offer minimal scarring, faster recovery, and improved safety. Factors like patient comfort, shorter surgery duration, and cost-effectiveness also contribute to the growing demand for these treatments. Consequently, the market is expected to expand due to these factors significantly.
What restraints the growth of the tumor ablation market?
“High cost of surgeries”
The escalating expenses associated with surgeries, including open surgery, laparoscopic procedures, and percutaneous interventions, challenge market growth. The high costs make it difficult for developing countries to incorporate these surgical techniques in their healthcare facilities, resulting in slower treatment processes. Consequently, the market's growth is hindered by the financial barriers and healthcare providers' limitations in adopting these costly surgical procedures.
Segmentation: Tumor Ablation Market
The tumor ablation market is segmented on the basis of type, types of treatment, technology, application, end user, and distribution channel.
- On the basis of type, the tumor ablation market has been segmented into chemical ablation, thermal ablation, and others.
- On the basis of types of treatment, the tumor ablation market has been segmented into open surgery, laparoscopic and percutaneous.
- On the basis of technology, the tumor ablation market has been segmented into radiofrequency, microwave, cryoablation, irreversible electroporation (ire), high intensity focused ultrasound (hifu), laser, fluoroscopy, ultrasound, ct, MRI imaging, and others.
- On the basis of application, the tumor ablation market has been segmented into liver, kidney, bone, lung, uterine fibroid, prostate, breast, and others.
- On the basis of end user, the tumor ablation market has been segmented into hospitals, oncology center, and others.
- On the basis of distribution channel, the tumor ablation market has been segmented into direct sales and third party distributors.
To know more about the study visit, https://www.databridgemarketresearch.com/ar/reports/switzerland-tumor-ablation-market
The Prominent Key Players Operating in the Tumor Ablation Market Include:
- Medtronic (Ireland)
- AngioDynamics (U.S.)
- Boston Scientific Corporation (U.S.)
- BIOTRONIK SE & Co KG (Germany)
- EDAP TMS (France)
- HealthTronics, Inc. (U.S.)
- Misonix (U.S.)
- Medical Devices Business Services, Inc. (U.S.)
- Erbe Elektromedizin GmbH (Germany)
- MERMAID MEDICAL A/S (Denmark)
- BTG International Ltd (U.K.)
- BVM Medical Limited (U.K.)
- COMSOL INC. (Sweden)
- Cortex Technology (Denmark)
- CooperSurgical, Inc. (U.S.)
- AtriCure, Inc (U.S.)
- Abbott (U.S.)
- Integra LifeSciences (U.S.)
- Smith+Nephew (U.K.)
- CONMED Corporation (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of tumor ablation market companies contact, https://www.databridgemarketresearch.com/ar/contact
Research Methodology: Switzerland Tumor Ablation Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Switzerland vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
